In vitro study of α-synuclein protofibrils by Cryo-EM suggests a Cu2+-dependent aggregation pathway

Biophysical Journal

Volumn 104, Issue 12, 2013, Pages 2706-2713

  Zhang, Hangyu ^a   Griggs, Amy ^b   Rochet, Jean Christophe ^b   Stanciu, Lia A ^a,c  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; COPPER;

ANIMAL; CHEMISTRY; CRYOELECTRON MICROSCOPY; HUMAN; METABOLISM; PROTEIN MULTIMERIZATION; ULTRASTRUCTURE;

ALPHA-SYNUCLEIN; AMYLOID; ANIMALS; COPPER; CRYOELECTRON MICROSCOPY; HUMANS; PROTEIN MULTIMERIZATION;

EID: 84879229182     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2013.04.050     Document Type: Article

References (38)

1. L.M.L. de Lau, and M.M.B. Breteler Epidemiology of Parkinson's disease Lancet Neurol. 5 2006 525 535
2. C.W. Olanow, M.D. Stern, and K. Sethi The scientific and clinical basis for the treatment of Parkinson disease Neurology 72 2009 S65 S73
3. A.L. Fink The aggregation and fibrillation of α-synuclein Acc. Chem. Res. 39 2006 628 634
4. B. Caughey, and P.T. Lansbury Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders Annu. Rev. Neurosci. 26 2003 267 298
5. M.S. Goldberg, and P.T. Lansbury Jr. Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? Nat. Cell Biol. 2 2000 E115 E119
6. C.A. Ross, and M.A. Poirier Protein aggregation and neurodegenerative disease Nat. Med. 10 Suppl 2004 S10 S17
7. F. Chiti, and C.M. Dobson Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75 2006 333 366
8. H. Zhang, H. Luo, and X. Zhao Mechanistic study of self-assembling peptide RADA16-I in formation of nanofibers and hydrogels J.Nanotechnol. Eng. Med 1 2010 011007-011006
9. L.P. Ruan, and H.Y. Zhang X. Zhao Designed amphiphilic peptide forms stable nanoweb, slowly releases encapsulated hydrophobic drug, and accelerates animal hemostasis Proc. Natl. Acad. Sci. USA 106 2009 5105 5110
10. M. Bucciantini, and E. Giannoni M. Stefani Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
11. Z. Ye, and H. Zhang X. Zhao Temperature and pH effects on biophysical and morphological properties of self-assembling peptide RADA16-I J. Pept. Sci. 14 2008 152 162
12. R. Kayed, and E. Head C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
13. B.D. van Rooijen, M.M. Claessens, and V. Subramaniam Membrane permeabilization by oligomeric α-synuclein: in search of the mechanism PLoS ONE 5 2010 e14292
14. K.A. Conway, and S.J. Lee P.T. Lansbury Jr. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc. Natl. Acad. Sci. USA 97 2000 571 576
15. K.A. Conway, J.D. Harper, and P.T. Lansbury Jr. Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid Biochemistry 39 2000 2552 2563
16. T.T. Ding, and S.J. Lee P.T. Lansbury Jr. Annular α-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes Biochemistry 41 2002 10209 10217
17. H.A. Lashuel, and B.M. Petre P.T. Lansbury Jr. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils J. Mol. Biol. 322 2002 1089 1102
18. H.A. Lashuel, and D. Hartley P.T. Lansbury Jr. Neurodegenerative disease: amyloid pores from pathogenic mutations Nature 418 2002 291
19. R. Kayed, and A. Pensalfini C. Glabe Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer J. Biol. Chem. 284 2009 4230 4237
20. H.A. Lashuel, and D.M. Hartley P.T. Lansbury Jr. Mixtures of wild-type and a pathogenic (E22G) form of Aβ40 in vitro accumulate protofibrils, including amyloid pores J. Mol. Biol. 332 2003 795 808
21. H. Lin, R. Bhatia, and R. Lal Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology FASEB J. 15 2001 2433 2444
22. F. Sokolowski, and A.J. Modler D. Naumann Formation of critical oligomers is a key event during conformational transition of recombinant Syrian hamster prion protein J. Biol. Chem. 278 2003 40481 40492
23. Y. Porat, and S. Kolusheva E. Gazit The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies Biochemistry 42 2003 10971 10977
24. H.A. Lashuel, and P.T. Lansbury Jr. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q. Rev. Biophys. 39 2006 167 201
25. A. Quist, and I. Doudevski R. Lal Amyloid ion channels: a common structural link for protein-misfolding disease Proc. Natl. Acad. Sci. USA 102 2005 10427 10432
26. H. Jang, and F.T. Arce R. Nussinov Misfolded amyloid ion channels present mobile β-sheet subunits in contrast to conventional ion channels Biophys. J. 97 2009 3029 3037
27. D.-P. Hong, A.L. Fink, and V.N. Uversky Structural characteristics of α-synuclein oligomers stabilized by the flavonoid baicalein J. Mol. Biol. 383 2008 214 223
28. A. Dusa, and J. Kaylor A.L. Fink Characterization of oligomers during α-synuclein aggregation using intrinsic tryptophan fluorescence Biochemistry 45 2006 2752 2760
29. J. Kong, and S. Yu Fourier transform infrared spectroscopic analysis of protein secondary structures Acta Biochim. Biophys. Sin. (Shanghai) 39 2007 549 559
30. S. De Carlo, and J.R. Harris Negative staining and cryo-negative staining of macromolecules and viruses for TEM Micron 42 2011 117 131
31. M. Adrian, and J. Dubochet J.R. Harris Cryo-negative staining Micron 29 1998 145 160
32. H.B. Jang, and J. Zheng R. Nussinov New structures help the modeling of toxic amyloidβ ion channels Trends Biochem. Sci. 33 2008 91 100
33. J.D. Harper, C.M. Lieber, and P.T. Lansbury Jr. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein Chem. Biol. 4 1997 951 959
34. M.P. Lambert, and A.K. Barlow W.L. Klein Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. USA 95 1998 6448 6453
35. D.M. Walsh, and A. Lomakin D.B. Teplow Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate J. Biol. Chem. 272 1997 22364 22372
36. M. Vilar, and H.T. Chou R. Riek The fold of α-synuclein fibrils Proc. Natl. Acad. Sci. USA 105 2008 8637 8642
37. R.M. Rasia, and C.W. Bertoncini C.O. Fernández Structural characterization of copper(II) binding to α-synuclein: insights into the bioinorganic chemistry of Parkinson's disease Proc. Natl. Acad. Sci. USA 102 2005 4294 4299
38. V.N. Uversky, J. Li, and A.L. Fink Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure J. Biol. Chem. 276 2001 44284 44296